A Study of Acalabrutinib Plus Venetoclax and Rituximab in Participants With Treatment Na ïve Mantle Cell Lymphoma

Condition:   Mantle Cell Lymphoma (MCL) Interventions:   Drug: Acalabrutinib;   Drug: Venetoclax;   Drug: Rituximab Sponsor:   AstraZeneca Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials